Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development
Organometallic ruthenium compounds that are effective anticancer and antimetastasis agents are currently under intensive investigation (see also the article by Peter Sadler in this issue). This article provides a personal account of the way in which we have exploited the different propertie...
Main Author: | |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2007-11-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://chimia.ch/chimia/article/view/4394 |